1. Introduction {#s0005}
===============

There were 13,170 new cases of cervical cancer diagnosed in 2019 in the US ([@b0045]). In many countries, formal screening programs have led to the dramatic decrease in mortality of cervical cancer. This is due, in part, to improved detection of early-stage cancers. Despite diagnosis at early stages, up to 20% of early stage cervical cancers recur ([@b0030]). Generally, recurrent cervical cancer has a poor prognosis as it is not curable. Median survival rates for symptomatic patients ranges from 8 to 38 months and 8--53 months for asymptomatic patients ([@b0030]). Most recurrences are detected at the time of pelvic exam with symptoms local to the pelvis such as pain or bleeding. The most common sites for local recurrence include the pelvic floor or lymph nodes ([@b0050]). While less common, sites for distant hematogenous recurrence include lung, liver or bone ([@b0025]). Here, we present a more unique presentation of recurrent cervical cancer associated with an unusual pattern of spread to the abdominal wall.

2. Case report {#s0010}
==============

A 44 year old initially presented with abnormal pap screening and was diagnosed with a stage IB1 high grade squamous cell carcinoma of the cervix. She was treated with laparoscopic radical hysterectomy and pelvic lymph node dissection for a 3 cm high grade tumor with no intermediate or high pathologic risk factors for recurrence. No adjuvant treatment was recommended, and she was lost to follow up after her postoperative visits.

Two years later, the patient presented to the Emergency Department with a three-month history of abdominopelvic pain and a warm, erythematous infraumbilical abdominal wall. She reported associated constipation and weight loss of 20 lbs. Physical exam revealed an approximately 7 cm indurated area in her lower abdominal wall. She had associated erythema and warmth, consistent with a clinical diagnosis of cellulitis ([Fig. 1](#f0005){ref-type="fig"}). She was afebrile with normal vital signs, but had a leukocytosis to 24 as well as thrombocytosis. CT scan revealed a lobulated mass with cystic areas measuring 9.5 cm × 11 cm extending from immediately anterior to the sigmoid colon through the abdominal wall ([Fig. 2](#f0010){ref-type="fig"}a). There was suspicion of involvement of the small bowel and the superior urinary bladder.Fig. 1Gross view of abdominal wall on presentation.Fig. 2**2a**: CT image of patient at initial presentation. **2b**: CT image of patient after three cycles of chemotherapy but prior to surgical resection.

Due to concern for cellulitis with possible recurrence of cervical cancer, the patient was admitted for intravenous antibiotic therapy and biopsy of the mass. CT-guided biopsy showed squamous cell carcinoma staining for p40 and p16, suggesting a recurrence of her cervical tumor ([Fig. 3](#f0015){ref-type="fig"}). Multidisciplinary tumor conference recommendation was for neoadjuvant chemotherapy followed by surgical resection. She was treated with 3 cycles of carboplatin and paclitaxel with favorable response on CT scan ([Fig. 2](#f0010){ref-type="fig"}b) obtained preoperatively. She underwent exploratory laparotomy, en-bloc resection of the abdominal wall, a portion of the omentum and small bowel, followed by abdominal wall reconstruction with mesh. No involvement of the bladder wall was observed at the time of the operation, however the mass was adherent to one loop of small bowel and to the bladder peritoneum. The small bowel was resected with the mass, and the bladder peritoneum was resected and oversewn. Final pathology was consistent with poorly differentiated squamous cell carcinoma extending through the full thickness of small intestine involving omentum and soft tissues with widely negative margins.Fig. 3**3a**: H&E stain 100x magnification. **3b**: p40 stain for squamous differentiation of tumors. **3c**: p16 stain for high-risk HPV.

She was treated with 3 more cycles of chemotherapy. Within 3 months of completing chemotherapy, she recurred in her right inguinal lymph nodes. The inguinal node was biopsied and pathology was consistent with metastatic squamous cell carcinoma. She underwent treatment with weekly cisplatin and concurrent radiation to the whole pelvis and inguinal regions. At the time of the writing of this manuscript, she was without evidence of disease for 18 months following chemoradiation and was still in remission.

3. Discussion {#s0015}
=============

Abdominal wall recurrence with associated cellulitis is a rare presentation of recurrent cervical cancer. Between 10 and 20% of patients with stage I disease recur ([@b0010]). The most common symptoms of recurrence include vaginal bleeding, pain, fatigue and weight loss ([@b0030]). There are case reports, however, describing abdominal wall recurrences. Most of these involve port site or laparotomy incision recurrences presenting as either cutaneous lesions over scars or subcutaneous masses ([@b0015], [@b0020]). Only one was asymptomatic and found on imaging at the time of restaging scans for a pelvic recurrence. In a retrospective single institution case control study, there was a 1.3% incidence of recurrence in the surgical scar after radical hysterectomy ([@b0050]). To the knowledge of the authors, no reports showed cellulitis as the presenting symptom. Our patient's laparoscopic radical hysterectomy was performed in the standard fashion with a peri-umbilical trocar accompanied by right and left lower quadrant trochars. No suprapubic trochar was placed, which would be closest in proximity to the location of the recurrence. However, it is unclear whether this patient's recurrence was at an incision site due to its size, location and diffuse pattern. For patients with a cervical cancer history presenting with abdominal wall abnormalities, recurrence of their cancer must be a consideration.

Seventy-five percent of cervical cancer recurrences occur within the first 3 years after treatment ([@b0010]). This patient and the patients detailed in the case reports of port/incision site recurrences all recurred within the 3-year timeframe ([@b0015], [@b0020]). For this reason, the typical surveillance schedule involves a pelvic exam every 3--6 months for 2 years, then every 6 months for an additional 3 years (NCCN). Cytologic evaluation can be utilized to identify other lower genital tract dysplasia or local recurrence ([@b0030]).

Most cervical cancer recurrences are symptomatic. Studies show that between 63% and 87% of recurrences present with symptoms ([@b0005], [@b0035]). Data shows symptomatic recurrences portend a worse prognosis than asymptomatic recurrences. Noncompliance with routine surveillance exams may contribute to high rates of symptomatic recurrence with poor prognosis. Cervical cancer survivors may present to their primary care providers or emergency departments with symptomatic recurrences due to noncompliance with Gynecologic Oncology or discharge from the oncology practice after 5 years. Awareness of atypical recurrence patterns benefit not only Gynecologic Oncologists, but primary care providers as they care for cancer survivors.

The distribution of disease among women with recurrent cervical cancer can vary widely. The most common distribution of disease is centrally in the pelvic floor/cervix, in the lymphatics, or carcinomatosis ([@b0035]). There are, however, reports describing metastases in the cardiac muscle, bone, brain, lungs, and supraclavicular lymph nodes ([@b0040]). The case reports of women with port site/incisional recurrences reported some solitary recurrences on the skin, but others noted concurrent widespread metastases. A wide variety of metastatic sites can be involved with recurrent cervical cancer.

Atypical presentations and spread patterns may require unique treatment plans. Standard treatment for recurrent cervical cancer depends on location, distribution, and prior radiation therapy. For regional recurrence with no prior radiation, the NCCN recommendation would include surgery followed by radiation with or without chemotherapy. In this case, it was unlikely that an initial operation would have obtained negative margins, and the risk of bladder or bowel injury was high. For these reasons, neoadjuvant chemotherapy was recommended. Negative margins were reported at the time of the debulking surgery, and completion of a total of 6 cycles of chemotherapy was recommended without radiation. Radiation was not recommended due to the lack of any known residual disease in addition to the extent of the surgery including a small bowel anastomosis and a reconstructed abdominal wall. It is unclear whether adjuvant radiation would have prevented the recurrence in the inguinal node area.

In conclusion, this is an unusual recurrence of cervical cancer in its presenting symptoms and spread pattern. This patient required an individualized treatment plan and unfortunately has a poor long-term prognosis.
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